Imagen de Portada

Correction to “Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD : Evidence from NHANES 2011–2018”

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Respirology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Is there a role for chest wall mobilization in the management of COPD?
por: Annemarie L. Lee, et al.
Publicado: (2024)

Diffusion capacity and static hyperinflation as markers of disease progression predict 3‐year mortality in COPD: Results from COSYCONET
por: Hendrik Pott, et al.
Publicado: (2024)

Form Is Function: Predicting COPD Outcomes With Respiratory Muscle Dysfunction
por: Bartolome R. Celli
Publicado: (2025)

Asthma‐COPD overlap and asthma progressing to COPD: A complementary perspective
por: Christine F. McDonald, et al.
Publicado: (2024)

Enhancing COPD Care for Women: A Predictive Tool for Palliative Needs
por: Syed Ahmar Shah
Publicado: (2025)

Missing Millions With COPD
por: John R. Hurst
Publicado: (2025)

Breathless and heart broken in COPD
por: John R. Hurst
Publicado: (2024)

COPD: The forgotten cardiovascular risk
por: Belinda Cochrane
Publicado: (2024)

Asthma‐COPD overlap and asthma progressing to COPD: Are we using the right diagnostic approaches and pathways?
por: Elvis Malcolm Irusen, et al.
Publicado: (2024)

Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly
por: Chin Kook Rhee, et al.
Publicado: (2025)

Transforming recruitment to clinical trials in COPD
por: Tanya Patrick, et al.
Publicado: (2024)

Inflammation‐induced loss of CFTR ‐expressing airway ionocytes in non‐eosinophilic asthma
por: Ling Chen, et al.
Publicado: (2024)

Pulmonary function testing in COPD: Anchoring clinical relevance
por: Bruce R. Thompson
Publicado: (2024)

Challenges in the Management of Asthma and COPD in the Asia‐Pacific Region
por: Fanny Wai San Ko, et al.
Publicado: (2026)

Rebranding COPD Care and Research in the 21st Century
por: Joan B. Soriano, et al.
Publicado: (2025)

COPD is associated with increased cardiovascular disease risk independent of phenotype
por: Kolton Cobb, et al.
Publicado: (2024)

An Important Step Towards Better Health Management for People With COPD
por: Brian J. Smith
Publicado: (2026)

Validation and Further Analysis of the COPD Exacerbation Recognition Tool ( CERT )
por: Xiangju Xing, et al.
Publicado: (2025)

Early Diagnosis of COPD —How Can we Do Better?
por: Shawn D. Aaron
Publicado: (2025)

Airway Mucus Plugs in COPD : A Potential Treatable Trait
por: Naoya Tanabe
Publicado: (2025)

Limitations of Self‐Reported Data in Evaluating COPD Phenotypes and Cardiovascular Risk
por: Ibrahim Nagmeldin Hassan
Publicado: (2025)

Turning Limitations Into Insights: The Path Forward for COPD and Cardiovascular Risk Research
por: Paula Rodriguez‐Miguelez, et al.
Publicado: (2025)

Relapsing eosinophilic pneumonia in a patient with recurrent breast cancer receiving abemaciclib plus endocrine therapy
por: Hiroaki Ogata, et al.
Publicado: (2024)

Epigenetic Scarring and a Vulnerable Mucus–Barrier Axis in Ex‐Smokers With COPD
por: Mitsuo Sato
Publicado: (2026)

High Airway‐To‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD
por: Nobuyasu Wakazono, et al.
Publicado: (2025)

Beyond Single Cytokines: Targeting Co‐Receptor CD131 in Asthma‐COPD Overlap
por: Chantal Donovan
Publicado: (2025)

Seeing the Unseen: Cell Population Data Reveal Distinct Inflammatory Phenotypes in Severe COPD
por: Makoto Ishii
Publicado: (2025)

Comment on “High Airway‐to‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD ”
por: Junyi Bai, et al.
Publicado: (2025)

Is fractional exhaled nitric oxide ready to be a biomarker? Within‐day variability in stable COPD
por: Inès Van Rossem, et al.
Publicado: (2024)

Treatable traits in pre‐COPD: Time to extend the treatable traits paradigm beyond established disease
por: Shyamali C. Dharmage, et al.
Publicado: (2024)

Real‐World Evaluation of a Rapid Multiplex PCR Panel in Adults Hospitalized With COPD Exacerbations
por: Charles Wong, et al.
Publicado: (2026)

Reply to ‘Comment on “High Airway‐to‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD ”’
por: Nobuyasu Wakazono, et al.
Publicado: (2025)

Feasibility of continued treatment with dupilumab in patients with type 2 inflammatory disease who developed eosinophilic pneumonia: 3 case reports
por: Masamitsu Hamakawa, et al.
Publicado: (2024)

CD131 antagonism blocks inflammation, emphysema and fibrosis in an asthma‐COPD overlap mouse model originating in early life
por: Hao Wang, et al.
Publicado: (2025)

Benralizumab‐resistant mucus plugs in severe asthma complicated by eosinophilic chronic rhinosinusitis
por: Masamitsu Hamakawa, et al.
Publicado: (2024)

Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis
por: Xinru Ran, et al.
Publicado: (2025)

Computed tomography mucus plugs and airway tree structure in patients with chronic obstructive pulmonary disease: Associations with airflow limitation, health‐related independence and mortality
por: Naoya Tanabe, et al.
Publicado: (2024)

Successful discontinuation of corticosteroids through remission induction therapy with benralizumab for chronic eosinophilic pneumonia
por: Yoshiro Kai, et al.
Publicado: (2024)

Benefits of chest wall mobilization on respiratory efficiency and functional exercise capacity in people with severe chronic obstructive pulmonary disease (COPD): A randomized controlled trial
por: Amy Ying Yu Tsui, et al.
Publicado: (2024)

Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease ( GOLD ) and the Global Initiative for Asthma ( GINA )
por: David M. G. Halpin, et al.
Publicado: (2026)